🇺🇸 FDA
Patent

US 8124101

Genetically engineered swine influenza virus and uses thereof

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 8124101 (Genetically engineered swine influenza virus and uses thereof) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/544, A61K2039/552